Clinical Trials Directory

Trials / Unknown

UnknownNCT02687022

Measurement Repeatability in Contemporary Aberrometry

A Comparative Study of Measurement Repeatability for Two Aberrometers

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Moorfields Eye Hospital NHS Foundation Trust · Academic / Other
Sex
All
Age
21 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Wavefront scans are a common form of diagnostic test applied in preparing patients for laser eye surgery. An optical map of the eye is created by wavefront scanning, and information from these maps is used to program lasers used to correct focusing errors in the eye. Here the investigators are comparing how repeatable measurements are with a new wavefront scanner and one that is already in widespread use.

Detailed description

Aberrometers are used to measure each element of defocus (aberration) in an optical system. In LASIK, information derived from aberrometry (scans performed using aberrometers) is used to program the pattern of laser pulses delivered by an excimer laser in therapeutic reshaping of the cornea to correct defocus. To do this accurately, aberrometry findings need to be repeatable and correspond closely to manifest refraction. Here the investigators compare repeatability of measurements for a new aberrometer (Peramis) versus the aberrometer most widely used in contemporary wavefront guided laser vision correction (iDesign). The test aberrometer will be: Peramis (Schwind Eye-tech Solutions, Kleinostheim, Germany). Control aberrometer will be: iDesign (AMO, Santa Clara, CA)

Conditions

Interventions

TypeNameDescription
DEVICEPeramis aberrometryA non-invasive photographic scan sequence acquired in under 10 seconds
DEVICEiDesign aberrometryA non-invasive photographic scan sequence acquired in under 10 seconds

Timeline

Start date
2016-03-01
Primary completion
2016-06-01
Completion
2016-09-01
First posted
2016-02-22
Last updated
2016-02-22

Source: ClinicalTrials.gov record NCT02687022. Inclusion in this directory is not an endorsement.